Cargando…

Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy

Erythrocytes or red blood cells (RBCs) represent a promising cell-mediated drug delivery platform due to their inherent biocompatibility. Here, we developed an antigen delivery system based on the nanoerythrosomes derived from RBCs, inspired by the splenic antigen-presenting cell targeting capacity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xiao, Shen, Shufang, Fan, Qin, Chen, Guojun, Archibong, Edikan, Dotti, Gianpietro, Liu, Zhuang, Gu, Zhen, Wang, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810293/ https://www.ncbi.nlm.nih.gov/pubmed/31681841 http://dx.doi.org/10.1126/sciadv.aaw6870

Ejemplares similares

Nanoerythrosome-functionalized biohybrid microswimmers
por: Buss, Nicole, et al.
Publicado: (2020)

Utilizing induced neural stem cell‐based delivery of a cytokine cocktail to enhance chimeric antigen receptor‐modified T‐cell therapy for brain cancer
por: Woodell, Alex S., et al.
Publicado: (2023)

Metformin-loaded nanoerythrosomes: An erythrocyte-based drug delivery system as a therapeutic tool for glioma
por: Moezzi, Seyed Mohammad Iman, et al.
Publicado: (2023)

Chronicles of Nanoerythrosomes: An Erythrocyte-Based Biomimetic Smart Drug Delivery System as a Therapeutic and Diagnostic Tool in Cancer Therapy
por: Javed, Shamama, et al.
Publicado: (2021)

Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma
por: Ogunnaike, Edikan A., et al.
Publicado: (2021)

Cryo-shocked cancer cells for targeted drug delivery and vaccination
por: Ci, Tianyuan, et al.
Publicado: (2020)

Scattered seeding of CAR T cells in solid tumors augments anticancer efficacy
por: Li, Hongjun, et al.
Publicado: (2021)

Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
por: Agarwalla, Pritha, et al.
Publicado: (2022)

The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
por: Liu, Dongfang, et al.
Publicado: (2020)

Adipocytes Encapsulating Telratolimod Recruit and Polarize Tumor‐Associated Macrophages for Cancer Immunotherapy
por: Wen, Di, et al.
Publicado: (2022)

Catch me if you can: how AML and its niche escape immunotherapy
por: Tettamanti, Sarah, et al.
Publicado: (2021)

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
por: Grada, Zakaria, et al.
Publicado: (2013)

ON THE ANTIGENS OF RED BLOOD CORPUSCLES : THE QUESTION OF LIPOID ANTIGENS.
por: Landsteiner, K., et al.
Publicado: (1925)

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
por: Karlsson, Hannah, et al.
Publicado: (2015)

Activation and degranulation of CAR-T cells using engineered antigen-presenting cell surfaces
por: Dirar, Qassim, et al.
Publicado: (2020)

Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
por: Xiong, Wei, et al.
Publicado: (2018)

Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
por: Xiong, Wei, et al.
Publicado: (2021)

Editorial: Novel Platform for Antigen Delivery to Dendritic Cells for Immunotherapy
por: Plantinga, Maud, et al.
Publicado: (2022)

Red cell antigen phenotypes in blood donors & thalassaemia patients for creation of red cell antigen-matched inventory
por: Kulkarni, Swati, et al.
Publicado: (2020)

Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
por: Li, Hongjun, et al.
Publicado: (2021)

Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy
por: Chenal, Alexandre, et al.
Publicado: (2018)

Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging
por: Mohanty, Joy G., et al.
Publicado: (2014)

Expression profiling of circulating non-red blood cells in embryonic blood
por: McIntyre, Brendan AS, et al.
Publicado: (2008)

Proteome expression profiling of red blood cells during the tumorigenesis of hepatocellular carcinoma
por: Wang, Shufang, et al.
Publicado: (2022)

Computationally Guided Design of Single-Chain Variable Fragment Improves Specificity of Chimeric Antigen Receptors
por: Krokhotin, Andrey, et al.
Publicado: (2019)

Red blood cells: a potential delivery system
por: Chen, Mengran, et al.
Publicado: (2023)

Red blood cell antigen alloimmunization: Mysteries still unsolved
por: Garraud, Olivier
Publicado: (2016)

Stimuli-Responsive Polymeric Nanomaterials for the Delivery of Immunotherapy Moieties: Antigens, Adjuvants and Agonists
por: Nagareddy, Raveena, et al.
Publicado: (2021)

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
por: Reppel, Loïc, et al.
Publicado: (2022)

Innovative delivery systems for epicutaneous immunotherapy
por: Wang, Zhen, et al.
Publicado: (2023)

Nucleic Acid Delivery with Red-Blood-Cell-Based Carriers
por: Della Pelle, Giulia, et al.
Publicado: (2021)

Natural blood plasma-based hydrogels as tumor vaccines delivery systems to enhance biomimetic recruitment of antigen presenting cells for tumor immunotherapy
por: Huang, Linghong, et al.
Publicado: (2022)

Prevalence of Red Blood Cell Major Blood Group Antigens and Phenotypes among Omani Blood Donors
por: Al-Riyami, Arwa Z., et al.
Publicado: (2019)

Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
por: Zhuang, Jia, et al.
Publicado: (2019)

Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy
por: Li, Jiong, et al.
Publicado: (2022)

Albumin Glycation Affects the Delivery of C-Peptide to the Red Blood Cells
por: Jacobs, Monica J., et al.
Publicado: (2022)

ON THE ANTIGENS OF RED BLOOD CORPUSCLES : II. FLOCCULATION REACTIONS WITH ALCOHOLIC EXTRACTS OF ERYTHROCYTES.
por: Landsteiner, K., et al.
Publicado: (1925)

Preservation of red blood cell antigenicity in a new storage solution in vitro
por: Tang, Sheng-Hui, et al.
Publicado: (2022)

Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma
por: Sun, Chuang, et al.
Publicado: (2019)

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma
por: Mahaweni, Niken M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s5tc2bpvhm15og58e8q5jeu90v